甲状腺髓样癌区室特异性复发模式的多中心回顾性队列研究
这项多中心回顾性队列研究纳入235例接受手术的甲状腺髓样癌(MTC)成人患者,评估淋巴结清扫与区室特异性复发的关系。总体复发率31%,同侧中央区和同侧侧颈区各占15%,对侧中央区仅5%;在cN0亚组中,对侧预防性中央颈清扫(pCND)与总体复发及对侧中央区复发差异小且估计不精确。
要点
- MTC术后最常见复发部位为同侧中央区和同侧侧颈区。
- 对侧中央区复发不常见,但置信区间宽,无法确定对侧pCND的获益。
- cN0患者中对侧pCND与复发差异小且不精确,需更大样本研究。
核心结论
- MTC中最常见复发部位为同侧中央区和同侧侧颈区,对侧中央区复发不常见。
- 对侧pCND是否降低复发风险尚无定论,宽置信区间不支持确定性结论,需更大规模研究。
研究设计与样本
- 多中心回顾性队列研究,纳入1998至2021年间在4家学术转诊中心接受甲状腺切除术的成人MTC患者235例。
- 中位年龄56岁(IQR 43-66岁),女性132例(56%);术前cN0者105例(45%),其中58例(55%)接受对侧pCND。
- 排除缺失手术数据(包括初始甲状腺切除术信息和中央颈清扫侧别)的患者。
主要发现
- 73例(31%)出现复发:同侧中央区15%、同侧侧颈区15%、对侧中央区5%、对侧侧颈区8%、远处转移11%、生化复发4%。
- cN0患者中,接受与未接受对侧pCND者的总体复发率分别为22%与15%(RD 0.07,95%CI -0.07至0.22)。
- cN0患者中,对侧中央区复发率分别为5%与2%(RD 0.03,95%CI -0.04至0.10)。
- 多因素分析(校正性别、肿瘤大小和淋巴结受累)显示,对侧pCND与总体复发(HR 0.59,95%CI 0.21-1.62)及对侧颈复发(HR 0.23,95%CI 0.02-3.08)降低无关。
关键数值与推荐
- 生化复发定义为降钙素>2 pg/mL且无影像学发现。
- 127例(54%)接受基因检测,胚系RET变异率为25%。
临床怎么用
- MTC术后随访应重点关注同侧中央区和同侧侧颈区复发。
- 对cN0患者行对侧pCND的获益证据不确定,决策需个体化并考虑宽置信区间。
局限性
- 回顾性设计可能存在选择偏倚和混杂。
- 对侧pCND相关效应的置信区间宽,不能排除潜在获益或危害。
- 部分患者缺失手术数据被排除,可能影响代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Total thyroidectomy with bilateral central neck dissection is recommended for medullary thyroid carcinoma (MTC), even in patients without clinical nodal involvement. However, the role of contralateral prophylactic central neck dissection (pCND) remains debated, leading to variations in practice. OBJECTIVE: To evaluate the outcomes of nodal dissection in compartment-specific recurrence in patients undergoing surgical treatment for MTC, including a subgroup analysis of patients with preoperative clinically node-negative (cN0) disease stratified by whether they underwent contralateral pCND. DESIGN, SETTING, AND PARTICIPANTS: This was a multicenter retrospective cohort study of adult patients with MTC who underwent thyroidectomy between 1998 and 2021 in 4 academic referral centers. Data were analyzed from February to July 2026. Patients with missing operative data, including initial thyroidectomy information and central neck dissection laterality, were excluded. EXPOSURE: Contralateral pCND at the time of initial surgical treatment. MAIN OUTCOMES AND MEASURES: Recurrence categorized as biochemical (calcitonin >2 pg/mL without radiographic findings); ipsilateral central, ipsilateral lateral, contralateral central, and contralateral lateral neck; and distant metastatic. Effect size was reported as Rosenthal r (r) for continuous variables and as risk difference (RD) with 95% CIs for categorical variables. Multivariable Cox regression was used to evaluate risk factors for contralateral neck recurrence and overall recurrence. RESULTS: This study in a total of 235 patients who underwent surgical treatment for MTC (132 [56%] female; median age, 56 years [IQR, 43-66 years]) found that, preoperatively, 105 patients (45%) had cN0 disease, of whom 58 (55%) underwent contralateral pCND. Genetic testing was performed in 127 (54%) patients, with a 25% rate of germline RET variant. Overall, 73 patients (31%) developed disease recurrence: 15% in the ipsilateral central, 15% ipsilateral lateral, 5% contralateral central, and 8% contralateral lateral neck; 11% distant metastatic; and 4% biochemical. Among patients with cN0 disease, differences in the rates of overall recurrence (22% vs 15%; RD, 0.07; 95% CI, -0.07 to 0.22) and contralateral central neck recurrence (5% vs 2%; RD, 0.03; 95% CI, -0.04 to 0.10) were small and imprecisely estimated between those who did and did not undergo contralateral pCND. On multivariable analysis adjusting for sex, tumor size, and nodal involvement, contralateral pCND was not associated with reduced overall recurrence (hazard ratio [HR], 0.59; 95% CI, 0.21-1.62) or contralateral neck recurrence (HR, 0.23; 95% CI, 0.02-3.08). CONCLUSIONS AND RELEVANCE: This study found that, in MTC, the most frequent sites of recurrence were the ipsilateral central and lateral neck. Contralateral central neck recurrence was uncommon; however, our wide CIs preclude definitive conclusions about the benefit of contralateral pCND, and larger studies are warranted.
引用
- Seo YJ, Larios KN, Mao YV, et al. Compartment-Specific Recurrence in Medullary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42690646. doi:10.1001/jamaoto.2026.2597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。